Overview

Location [1]
19p13.2
Protein [2]
Mucin-16
Synonyms [1]
CA125

MUC16 is altered in 2.82% of all cancers with breast invasive ductal carcinoma, breast invasive lobular carcinoma, mixed lobular and ductal breast carcinoma, and breast neoplasm having the greatest prevalence of alterations [3].

MUC16 GENIE Cases - Top Diseases

The most common alterations in MUC16 are MUC16 Amplification (0.25%) and MUC16 Loss (0.00%) [3].

MUC16 GENIE Cases - Top Alterations

Significance of MUC16 in Diseases

Fallopian Tube Carcinoma +

Primary Peritoneal Carcinoma +

Ovarian Carcinoma +

Malignant Ovarian Epithelial Tumor +

Ovarian Epithelial Tumor +

Pancreatic Ductal Adenocarcinoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.